Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 12:08:17 +0200Mon, 29 Apr 2024 14:17:00 +0200Human medicines European public assessment report (EPAR): Xgeva, denosumab, Date of authorisation: 13/07/2011, Revision: 25, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/xgevaHuman medicines European public assessment report (EPAR): Xgeva, denosumab, Date of authorisation: 13/07/2011, Revision: 25, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/xgevaMon, 29 Apr 2024 14:17:00 +0200Human medicineXgeva : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-2173-en.pdfXgeva : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-2173-en.pdfMon, 29 Apr 2024 11:29:00 +0200Human medicine